Switch to:
More From Other Websites
AstraZeneca reboots psoriasis drug in development deal with Valeant Sep 01 2015
Valeant Strikes Psoriasis-Drug Pact With AstraZeneca Sep 01 2015
Cholesterol-fighting 'game changer': Alnylam CEO Aug 31 2015
​Trial suggests Alnylam's cholesterol-lowering drug may last longer than Amgen's Aug 30 2015
​Amgen wins FDA approval for cholesterol drug Repatha Aug 28 2015
Gilead & Amgen Account for Nearly 75% of the Biotech Profit Pool Aug 28 2015
Amgen v. Regeneron: Everyone Wins? Aug 28 2015
Amgen's PCSK9 Inhibitor, Repatha, Approved in the U.S. Aug 28 2015
How Amgen Can Disrupt the Market for Cholesterol Drugs Aug 28 2015
Time to Buy Amgen After Newly Approved Drug? Aug 28 2015
Early movers: BIG, MYL, FCX, BGS, FB, ADSK & more Aug 28 2015
Amgen approved for pricey new drug Aug 28 2015
PRESS DIGEST- New York Times business news - August 28 Aug 28 2015
FDA Approves Amgen’s Cholesterol-Lowering Drug Repatha Aug 27 2015
The New Cholesterol Lowering Drugs Epitomize The Drug Pricing Battles Aug 27 2015
Amgen wins approval for second biotech cholesterol drug Aug 27 2015
Amgen wins approval for second biotech cholesterol drug Aug 27 2015
FDA approves Amgen cholesterol-lowering drug Repatha for some patients Aug 27 2015
Amgen's Repatha OK'd With Similar Label To Praluent Aug 27 2015


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership

FEEDBACK